Patents by Inventor Markus Ferrari

Markus Ferrari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11357624
    Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: June 14, 2022
    Assignee: JenaValve Technology, Inc.
    Inventors: Volker Guyenot, Thomas Peschel, Christoph Damm, Hans-Reiner Figulla, Markus Ferrari, Johannes Jung
  • Patent number: 11116628
    Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).
    Type: Grant
    Filed: June 17, 2019
    Date of Patent: September 14, 2021
    Assignee: JenaValve Technology, Inc.
    Inventors: Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
  • Publication number: 20200268953
    Abstract: So as to be able to determine the position of a functional element as precisely as possible during the invasive use of a blood pump in a patient's body without the use of imaging methods, the blood pump is connected to a main sensor which records signals of the patient's heart, which are compared to other electrophysiological heart signals recorded by several sensors distributed on the body surface so as to allow the position of the blood pump to be determined by way of linking.
    Type: Application
    Filed: December 18, 2019
    Publication date: August 27, 2020
    Inventors: Markus Ferrari, Joerg Schumacher
  • Publication number: 20200179110
    Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.
    Type: Application
    Filed: December 10, 2019
    Publication date: June 11, 2020
    Applicant: JenaValve Technology, Inc.
    Inventors: Volker GUYENOT, Thomas PESCHEL, Christoph DAMM, Hans-Reiner FIGULLA, Markus FERRARI, Johannes JUNG
  • Publication number: 20200129290
    Abstract: The invention relates to a catheter for the transvascular implantation of prosthetic heart valves, in particular comprising self-expanding anchorage supports (10), which allow a minimally invasive implantation of prosthetic heart valves. The aim of the invention is to reduce the risk to the patient during the implantation. To achieve this, according to the invention a prosthetic heart valve comprising anchorage supports is temporarily housed in a folded form in a cartridge-type unit (4) during the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system (1), which comprises a flexible region (9) that can be guided through the aorta.
    Type: Application
    Filed: October 28, 2019
    Publication date: April 30, 2020
    Applicant: JENAVALVE TECHNOLOGY, INC.
    Inventors: Rüdiger OTTMA, Robert MOSZNER, Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM
  • Patent number: 10561773
    Abstract: So as to be able to determine the position of a functional element as precisely as possible during the invasive use of a blood pump in a patient's body without the use of imaging methods, the blood pump is connected to a main sensor which records signals of the patient's heart, which are compared to other electrophysiological heart signals recorded by several sensors distributed on the body surface so as to allow the position of the blood pump to be determined by way of linking.
    Type: Grant
    Filed: September 4, 2012
    Date of Patent: February 18, 2020
    Assignee: ECP ENTWICKLUNGSGESELLSCHAFT MBH
    Inventors: Markus Ferrari, Joerg Schumacher
  • Patent number: 10543084
    Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: January 28, 2020
    Assignee: JenaValve Technology, Inc.
    Inventors: Volker Guyenot, Thomas Peschel, Christoph Damm, Hans-Reiner Figulla, Markus Ferrari, Johannes Jung
  • Publication number: 20190365532
    Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).
    Type: Application
    Filed: June 17, 2019
    Publication date: December 5, 2019
    Applicant: JenaValve Technology, Inc.
    Inventors: Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM
  • Patent number: 10492906
    Abstract: A catheter is described for the transvascular implantation of prosthetic heart valves, e.g., including self-expanding anchorage supports, to reduce the risk to the patient during the implantation. Accordingly, a prosthetic heart valve with anchorage supports is temporarily housed in a folded form in a cartridge-type unit during the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system, which includes a flexible region that can be guided through the aorta. Actuating elements run through the interior of the hollow guide system, permitting sections of the cartridge-type unit to be displaced radially about their longitudinal axis and/or laterally in a proximal direction, thus allowing individual sections of the anchorage support and the associated prosthetic heart valve to be sequentially released.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: December 3, 2019
    Assignee: JenaValve Technology, Inc.
    Inventors: Rüdiger Ottma, Robert Moszner, Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
  • Patent number: 10363134
    Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: July 30, 2019
    Assignee: JenaValve Technology, Inc.
    Inventors: Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
  • Publication number: 20190008637
    Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.
    Type: Application
    Filed: February 6, 2018
    Publication date: January 10, 2019
    Applicant: JenaValve Technology, Inc.
    Inventors: Volker Guyenot, Thomas Peschel, Christoph Damm, Hans-Reiner Figulla, Markus Ferrari, Johannes Jung
  • Publication number: 20180318072
    Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).
    Type: Application
    Filed: November 22, 2017
    Publication date: November 8, 2018
    Applicant: JenaValve Technology, Inc.
    Inventors: Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM
  • Patent number: 9918835
    Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.
    Type: Grant
    Filed: April 14, 2016
    Date of Patent: March 20, 2018
    Assignee: JenaValve Technology, Inc.
    Inventors: Volker Guyenot, Thomas Peschel, Christoph Damm, Hans-Reiner Figulla, Markus Ferrari, Johannes Jung
  • Publication number: 20180021132
    Abstract: The invention relates to a catheter for the transvascular implantation of prosthetic heart valves, in particular comprising self-expanding anchorage supports (10), which allow a minimally invasive implantation of prosthetic heart valves. The aim of the invention is to reduce the risk to the patient during the implantation. To achieve this, according to the invention a prosthetic heart valve comprising anchorage supports is temporarily housed in a folded form in a cartridge-type unit (4) during the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system (1), which comprises a flexible region (9) that can be guided through the aorta.
    Type: Application
    Filed: September 11, 2017
    Publication date: January 25, 2018
    Applicant: JENAVALVE TECHNOLOGY, INC.
    Inventors: Rüdiger Ottma, Robert Moszner, Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
  • Patent number: 9855142
    Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: January 2, 2018
    Assignee: JenaValve Technologies, Inc.
    Inventors: Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
  • Patent number: 9788945
    Abstract: The invention relates to a catheter for the transvasculur implantation of prosthetic heart valves, in particular comprising self-expanding anchorage supports (10), which allow a minimally invasive implantation of prosthetic heart valves. The aim of the invention is to reduce the risk to the patient during the implantation. To achieve this, according to the invention a prosthetic heart valve comprising anchorage supports is temporarily housed in a folded form in a cartridge-type unit (4) riming the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system (1), which comprises a flexible region (9) that can be guided through the aorta.
    Type: Grant
    Filed: March 21, 2017
    Date of Patent: October 17, 2017
    Assignee: JENAVALVE TECHNOLOGY, INC.
    Inventors: Rüdiger Ottma, Robert Moszner, Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
  • Patent number: 9775705
    Abstract: A catheter is described for the transvascular implantation of prosthetic heart valves, e.g., including self-expanding anchorage supports, to reduce the risk to the patient during the implantation. Accordingly, a prosthetic heart valve with anchorage supports is temporarily housed in a folded form in a cartridge-type unit during the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system, which includes a flexible region that can be guided through the aorta. Actuating elements run through the interior of the hollow guide system, permitting sections of the cartridge-type unit to be displaced radially about their longitudinal axis and/or laterally in a proximal direction, thus allowing individual sections of the anchorage support and the associated prosthetic heart valve to be sequentially released.
    Type: Grant
    Filed: January 30, 2014
    Date of Patent: October 3, 2017
    Assignee: JenaValve Technology, Inc.
    Inventors: Rüdiger Ottma, Robert Moszner, Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
  • Publication number: 20170189184
    Abstract: The invention relates to a catheter for the transvasculur implantation of prosthetic heart valves, in particular comprising self-expanding anchorage supports (10), which allow a minimally invasive implantation of prosthetic heart valves. The aim of the invention is to reduce the risk to the patient during the implantation. To achieve this, according to the invention a prosthetic heart valve comprising anchorage supports is temporarily housed in a folded form in a cartridge-type unit (4) riming the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system (1), which comprises a flexible region (9) that can be guided through the aorta.
    Type: Application
    Filed: March 21, 2017
    Publication date: July 6, 2017
    Applicant: JENAVALVE TECHNOLOGY, INC.
    Inventors: Rüdiger OTTMA, Robert MOSZNER, Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM
  • Publication number: 20160374803
    Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).
    Type: Application
    Filed: June 28, 2016
    Publication date: December 29, 2016
    Applicant: JenaValve Technology, Inc.
    Inventors: Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM
  • Publication number: 20160296326
    Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.
    Type: Application
    Filed: April 14, 2016
    Publication date: October 13, 2016
    Applicant: JenaValve Technology, Inc.
    Inventors: Volker GUYENOT, Thomas PESCHEL, Christoph DAMM, Hans-Reiner FIGULLA, Markus FERRARI, Johannes JUNG